Weidong Xiao

机构：Army Medical University, Xinjiang Medical University, Sun Yat-sen University, Hohai University, Dalian Medical University, First Affiliated Hospital of Xinjiang Medical University, Wuhan University, Daping Hospital, Second Affiliated Hospital of Chongqing Medical University, Zhongnan Hospital of Wuhan University, Sun Yat-sen University Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Indiana University, Chongqing Medical University · ORCID：0000-0002-9300-980X

发表论文 181 篇 · 总被引 6083 次 · h-index 39

代表论文

• Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer (2021 · Frontiers in Oncology · 被引 48)
• Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy (2024 · Circulation Research · 被引 42)
• Exosomes Derived from Adipose Stem Cells Enhance Bone Fracture Healing via the Activation of the Wnt3a/β-Catenin Signaling Pathway in Rats with Type 2 Diabetes Mellitus (2023 · International Journal of Molecular Sciences · 被引 39)
• Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS (2022 · Molecular Therapy — Methods & Clinical Development · 被引 37)
• Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes (2022 · Molecular Therapy — Nucleic Acids · 被引 32)
• TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling (2023 · Molecular Therapy · 被引 27)